nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP3A4—type 2 diabetes mellitus	0.1	1	CbGaD
Tretinoin—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0674	0.137	CbGbCtD
Tretinoin—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0339	0.0688	CbGbCtD
Tretinoin—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0251	0.0508	CbGbCtD
Tretinoin—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.02	0.0406	CbGbCtD
Tretinoin—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.019	0.0386	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.019	0.0386	CbGbCtD
Tretinoin—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0181	0.0367	CbGbCtD
Tretinoin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0175	0.0355	CbGbCtD
Tretinoin—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0167	0.0339	CbGbCtD
Tretinoin—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0162	0.0328	CbGbCtD
Tretinoin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.016	0.0324	CbGbCtD
Tretinoin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0149	0.0301	CbGbCtD
Tretinoin—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0143	0.029	CbGbCtD
Tretinoin—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0132	0.0267	CbGbCtD
Tretinoin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0126	0.0256	CbGbCtD
Tretinoin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0126	0.0256	CbGbCtD
Tretinoin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0117	0.0237	CbGbCtD
Tretinoin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0114	0.0231	CbGbCtD
Tretinoin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0113	0.0228	CbGbCtD
Tretinoin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0103	0.0209	CbGbCtD
Tretinoin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0102	0.0206	CbGbCtD
Tretinoin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00958	0.0194	CbGbCtD
Tretinoin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0093	0.0189	CbGbCtD
Tretinoin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00919	0.0186	CbGbCtD
Tretinoin—CYP3A5—Losartan—type 2 diabetes mellitus	0.00883	0.0179	CbGbCtD
Tretinoin—CYP2C8—Losartan—type 2 diabetes mellitus	0.00849	0.0172	CbGbCtD
Tretinoin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00813	0.0165	CbGbCtD
Tretinoin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00735	0.0149	CbGbCtD
Tretinoin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00647	0.0131	CbGbCtD
Tretinoin—CYP2C9—Losartan—type 2 diabetes mellitus	0.00592	0.012	CbGbCtD
Tretinoin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00557	0.0113	CbGbCtD
Tretinoin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00534	0.0108	CbGbCtD
Tretinoin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00534	0.0108	CbGbCtD
Tretinoin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00505	0.0102	CbGbCtD
Tretinoin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00376	0.00763	CbGbCtD
Tretinoin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00344	0.00698	CbGbCtD
Tretinoin—GPRC5A—kidney—type 2 diabetes mellitus	0.00338	0.0722	CbGeAlD
Tretinoin—Vitamin A—RBP4—type 2 diabetes mellitus	0.00263	0.773	CrCbGaD
Tretinoin—RARRES1—adipose tissue—type 2 diabetes mellitus	0.00154	0.0329	CbGeAlD
Tretinoin—CRABP1—retina—type 2 diabetes mellitus	0.00153	0.0327	CbGeAlD
Tretinoin—ALDH1A2—nephron tubule—type 2 diabetes mellitus	0.00149	0.0319	CbGeAlD
Tretinoin—ALDH1A1—islet of Langerhans—type 2 diabetes mellitus	0.00135	0.0288	CbGeAlD
Tretinoin—ALDH1A2—cardiovascular system—type 2 diabetes mellitus	0.00134	0.0286	CbGeAlD
Tretinoin—RXRB—islet of Langerhans—type 2 diabetes mellitus	0.00133	0.0284	CbGeAlD
Tretinoin—ALDH1A2—cortex of kidney—type 2 diabetes mellitus	0.00128	0.0273	CbGeAlD
Tretinoin—CYP4A11—kidney—type 2 diabetes mellitus	0.00126	0.027	CbGeAlD
Tretinoin—CRABP1—cortex of kidney—type 2 diabetes mellitus	0.00123	0.0263	CbGeAlD
Tretinoin—CYP4A11—cortex of kidney—type 2 diabetes mellitus	0.00123	0.0263	CbGeAlD
Tretinoin—ALDH1A2—adipose tissue—type 2 diabetes mellitus	0.00118	0.0252	CbGeAlD
Tretinoin—RXRA—kidney—type 2 diabetes mellitus	0.00114	0.0243	CbGeAlD
Tretinoin—CRABP2—pancreas—type 2 diabetes mellitus	0.00114	0.0243	CbGeAlD
Tretinoin—ALDH1A1—nephron tubule—type 2 diabetes mellitus	0.00108	0.0232	CbGeAlD
Tretinoin—CRABP2—adipose tissue—type 2 diabetes mellitus	0.00103	0.022	CbGeAlD
Tretinoin—RXRG—cardiovascular system—type 2 diabetes mellitus	0.00102	0.0218	CbGeAlD
Tretinoin—RARG—retina—type 2 diabetes mellitus	0.00101	0.0215	CbGeAlD
Tretinoin—ALDH1A1—cardiovascular system—type 2 diabetes mellitus	0.000974	0.0208	CbGeAlD
Tretinoin—ALDH1A1—kidney—type 2 diabetes mellitus	0.000953	0.0204	CbGeAlD
Tretinoin—ALDH1A1—pancreas—type 2 diabetes mellitus	0.000946	0.0202	CbGeAlD
Tretinoin—RXRB—pancreas—type 2 diabetes mellitus	0.000933	0.02	CbGeAlD
Tretinoin—ALDH1A1—cortex of kidney—type 2 diabetes mellitus	0.000928	0.0198	CbGeAlD
Tretinoin—RXRG—adipose tissue—type 2 diabetes mellitus	0.000901	0.0193	CbGeAlD
Tretinoin—ALDH1A1—adipose tissue—type 2 diabetes mellitus	0.000859	0.0184	CbGeAlD
Tretinoin—ALDH1A2—liver—type 2 diabetes mellitus	0.000828	0.0177	CbGeAlD
Tretinoin—CYP4A11—liver—type 2 diabetes mellitus	0.000799	0.0171	CbGeAlD
Tretinoin—RARA—kidney—type 2 diabetes mellitus	0.000784	0.0168	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000771	0.0165	CbGeAlD
Tretinoin—RARG—adipose tissue—type 2 diabetes mellitus	0.000752	0.0161	CbGeAlD
Tretinoin—RXRA—liver—type 2 diabetes mellitus	0.000719	0.0154	CbGeAlD
Tretinoin—RARA—adipose tissue—type 2 diabetes mellitus	0.000707	0.0151	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00066	0.0141	CbGeAlD
Tretinoin—RARB—liver—type 2 diabetes mellitus	0.000646	0.0138	CbGeAlD
Tretinoin—ALDH1A1—liver—type 2 diabetes mellitus	0.000602	0.0129	CbGeAlD
Tretinoin—RXRB—liver—type 2 diabetes mellitus	0.000594	0.0127	CbGeAlD
Tretinoin—CYP2C18—liver—type 2 diabetes mellitus	0.000529	0.0113	CbGeAlD
Tretinoin—CYP3A7—liver—type 2 diabetes mellitus	0.000504	0.0108	CbGeAlD
Tretinoin—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000499	0.0107	CbGeAlD
Tretinoin—RARA—liver—type 2 diabetes mellitus	0.000496	0.0106	CbGeAlD
Tretinoin—Alitretinoin—CYP1A2—type 2 diabetes mellitus	0.000481	0.142	CrCbGaD
Tretinoin—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000428	0.00915	CbGeAlD
Tretinoin—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000396	0.00847	CbGeAlD
Tretinoin—CYP2A6—liver—type 2 diabetes mellitus	0.00035	0.00748	CbGeAlD
Tretinoin—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000319	0.00682	CbGeAlD
Tretinoin—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000317	0.00678	CbGeAlD
Tretinoin—CYP2C8—kidney—type 2 diabetes mellitus	0.000311	0.00664	CbGeAlD
Tretinoin—Acitretin—ALB—type 2 diabetes mellitus	0.00029	0.0853	CrCbGaD
Tretinoin—CYP1A1—kidney—type 2 diabetes mellitus	0.000287	0.00613	CbGeAlD
Tretinoin—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000285	0.00609	CbGeAlD
Tretinoin—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000282	0.00603	CbGeAlD
Tretinoin—CYP3A5—kidney—type 2 diabetes mellitus	0.00028	0.00599	CbGeAlD
Tretinoin—CYP2B6—kidney—type 2 diabetes mellitus	0.000279	0.00596	CbGeAlD
Tretinoin—CYP3A5—pancreas—type 2 diabetes mellitus	0.000279	0.00596	CbGeAlD
Tretinoin—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000273	0.00584	CbGeAlD
Tretinoin—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000258	0.00553	CbGeAlD
Tretinoin—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000253	0.0054	CbGeAlD
Tretinoin—CYP3A4—kidney—type 2 diabetes mellitus	0.00021	0.0045	CbGeAlD
Tretinoin—CYP2C8—liver—type 2 diabetes mellitus	0.000196	0.0042	CbGeAlD
Tretinoin—CYP1A1—liver—type 2 diabetes mellitus	0.000181	0.00388	CbGeAlD
Tretinoin—CYP3A5—liver—type 2 diabetes mellitus	0.000177	0.00379	CbGeAlD
Tretinoin—CYP2B6—liver—type 2 diabetes mellitus	0.000176	0.00377	CbGeAlD
Tretinoin—CYP2C9—liver—type 2 diabetes mellitus	0.000174	0.00373	CbGeAlD
Tretinoin—CYP3A4—liver—type 2 diabetes mellitus	0.000133	0.00284	CbGeAlD
Tretinoin—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000307	CcSEcCtD
Tretinoin—Myalgia—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000307	CcSEcCtD
Tretinoin—Shock—Metformin—type 2 diabetes mellitus	6.19e-05	0.000307	CcSEcCtD
Tretinoin—Insomnia—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Tretinoin—Malaise—Losartan—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Tretinoin—Anxiety—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Tretinoin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Tretinoin—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Tretinoin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.16e-05	0.000305	CcSEcCtD
Tretinoin—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.16e-05	0.000305	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000305	CcSEcCtD
Tretinoin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.15e-05	0.000305	CcSEcCtD
Tretinoin—Somnolence—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000305	CcSEcCtD
Tretinoin—Syncope—Losartan—type 2 diabetes mellitus	6.14e-05	0.000304	CcSEcCtD
Tretinoin—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.13e-05	0.000304	CcSEcCtD
Tretinoin—Discomfort—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000303	CcSEcCtD
Tretinoin—Skin disorder—Metformin—type 2 diabetes mellitus	6.11e-05	0.000303	CcSEcCtD
Tretinoin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.08e-05	0.000302	CcSEcCtD
Tretinoin—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000302	CcSEcCtD
Tretinoin—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.06e-05	0.0003	CcSEcCtD
Tretinoin—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.0003	CcSEcCtD
Tretinoin—Palpitations—Losartan—type 2 diabetes mellitus	6.05e-05	0.0003	CcSEcCtD
Tretinoin—Nausea—Glimepiride—type 2 diabetes mellitus	6.03e-05	0.000299	CcSEcCtD
Tretinoin—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000299	CcSEcCtD
Tretinoin—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.02e-05	0.000298	CcSEcCtD
Tretinoin—Nausea—Sitagliptin—type 2 diabetes mellitus	6.01e-05	0.000298	CcSEcCtD
Tretinoin—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.01e-05	0.000298	CcSEcCtD
Tretinoin—Asthenia—Glyburide—type 2 diabetes mellitus	6.01e-05	0.000298	CcSEcCtD
Tretinoin—Decreased appetite—Valsartan—type 2 diabetes mellitus	6e-05	0.000298	CcSEcCtD
Tretinoin—Anorexia—Metformin—type 2 diabetes mellitus	6e-05	0.000297	CcSEcCtD
Tretinoin—Cough—Losartan—type 2 diabetes mellitus	5.97e-05	0.000296	CcSEcCtD
Tretinoin—Urticaria—Gliclazide—type 2 diabetes mellitus	5.97e-05	0.000296	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.96e-05	0.000296	CcSEcCtD
Tretinoin—Alopecia—Ramipril—type 2 diabetes mellitus	5.96e-05	0.000296	CcSEcCtD
Tretinoin—Fatigue—Valsartan—type 2 diabetes mellitus	5.96e-05	0.000295	CcSEcCtD
Tretinoin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.94e-05	0.000295	CcSEcCtD
Tretinoin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.94e-05	0.000295	CcSEcCtD
Tretinoin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000294	CcSEcCtD
Tretinoin—Oedema—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000294	CcSEcCtD
Tretinoin—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000294	CcSEcCtD
Tretinoin—Pruritus—Glyburide—type 2 diabetes mellitus	5.92e-05	0.000294	CcSEcCtD
Tretinoin—Mental disorder—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000293	CcSEcCtD
Tretinoin—Constipation—Valsartan—type 2 diabetes mellitus	5.91e-05	0.000293	CcSEcCtD
Tretinoin—Infection—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000292	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.89e-05	0.000292	CcSEcCtD
Tretinoin—Fatigue—Orlistat—type 2 diabetes mellitus	5.88e-05	0.000292	CcSEcCtD
Tretinoin—Hypotension—Metformin—type 2 diabetes mellitus	5.88e-05	0.000292	CcSEcCtD
Tretinoin—Malnutrition—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000291	CcSEcCtD
Tretinoin—Erythema—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000291	CcSEcCtD
Tretinoin—Shock—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.00029	CcSEcCtD
Tretinoin—Pain—Orlistat—type 2 diabetes mellitus	5.84e-05	0.000289	CcSEcCtD
Tretinoin—Arthralgia—Losartan—type 2 diabetes mellitus	5.83e-05	0.000289	CcSEcCtD
Tretinoin—Chest pain—Losartan—type 2 diabetes mellitus	5.83e-05	0.000289	CcSEcCtD
Tretinoin—Myalgia—Losartan—type 2 diabetes mellitus	5.83e-05	0.000289	CcSEcCtD
Tretinoin—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.82e-05	0.000289	CcSEcCtD
Tretinoin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000289	CcSEcCtD
Tretinoin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.000288	CcSEcCtD
Tretinoin—Anxiety—Losartan—type 2 diabetes mellitus	5.81e-05	0.000288	CcSEcCtD
Tretinoin—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000287	CcSEcCtD
Tretinoin—Rash—Bromocriptine—type 2 diabetes mellitus	5.77e-05	0.000286	CcSEcCtD
Tretinoin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.77e-05	0.000286	CcSEcCtD
Tretinoin—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.000286	CcSEcCtD
Tretinoin—Tension—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000286	CcSEcCtD
Tretinoin—Discomfort—Losartan—type 2 diabetes mellitus	5.76e-05	0.000286	CcSEcCtD
Tretinoin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000285	CcSEcCtD
Tretinoin—Headache—Bromocriptine—type 2 diabetes mellitus	5.74e-05	0.000285	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.73e-05	0.000284	CcSEcCtD
Tretinoin—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.73e-05	0.000284	CcSEcCtD
Tretinoin—Nervousness—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000283	CcSEcCtD
Tretinoin—Dry mouth—Losartan—type 2 diabetes mellitus	5.7e-05	0.000283	CcSEcCtD
Tretinoin—Anorexia—Irbesartan—type 2 diabetes mellitus	5.66e-05	0.000281	CcSEcCtD
Tretinoin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.65e-05	0.00028	CcSEcCtD
Tretinoin—Paraesthesia—Metformin—type 2 diabetes mellitus	5.65e-05	0.00028	CcSEcCtD
Tretinoin—Confusional state—Losartan—type 2 diabetes mellitus	5.63e-05	0.000279	CcSEcCtD
Tretinoin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000279	CcSEcCtD
Tretinoin—Dyspnoea—Metformin—type 2 diabetes mellitus	5.61e-05	0.000278	CcSEcCtD
Tretinoin—Somnolence—Metformin—type 2 diabetes mellitus	5.59e-05	0.000277	CcSEcCtD
Tretinoin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.59e-05	0.000277	CcSEcCtD
Tretinoin—Oedema—Losartan—type 2 diabetes mellitus	5.59e-05	0.000277	CcSEcCtD
Tretinoin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.58e-05	0.000277	CcSEcCtD
Tretinoin—Infection—Losartan—type 2 diabetes mellitus	5.55e-05	0.000275	CcSEcCtD
Tretinoin—Hypotension—Irbesartan—type 2 diabetes mellitus	5.55e-05	0.000275	CcSEcCtD
Tretinoin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.54e-05	0.000275	CcSEcCtD
Tretinoin—Dyspepsia—Metformin—type 2 diabetes mellitus	5.54e-05	0.000275	CcSEcCtD
Tretinoin—Tremor—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000273	CcSEcCtD
Tretinoin—Shock—Losartan—type 2 diabetes mellitus	5.5e-05	0.000273	CcSEcCtD
Tretinoin—Urticaria—Valsartan—type 2 diabetes mellitus	5.49e-05	0.000272	CcSEcCtD
Tretinoin—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.48e-05	0.000272	CcSEcCtD
Tretinoin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.47e-05	0.000271	CcSEcCtD
Tretinoin—Decreased appetite—Metformin—type 2 diabetes mellitus	5.47e-05	0.000271	CcSEcCtD
Tretinoin—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000271	CcSEcCtD
Tretinoin—Tachycardia—Losartan—type 2 diabetes mellitus	5.45e-05	0.00027	CcSEcCtD
Tretinoin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.45e-05	0.00027	CcSEcCtD
Tretinoin—Nausea—Bromocriptine—type 2 diabetes mellitus	5.44e-05	0.00027	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.43e-05	0.000269	CcSEcCtD
Tretinoin—Fatigue—Metformin—type 2 diabetes mellitus	5.42e-05	0.000269	CcSEcCtD
Tretinoin—Urticaria—Orlistat—type 2 diabetes mellitus	5.42e-05	0.000269	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000268	CcSEcCtD
Tretinoin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.4e-05	0.000268	CcSEcCtD
Tretinoin—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000268	CcSEcCtD
Tretinoin—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000268	CcSEcCtD
Tretinoin—Asthenia—Gliclazide—type 2 diabetes mellitus	5.39e-05	0.000268	CcSEcCtD
Tretinoin—Agitation—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000268	CcSEcCtD
Tretinoin—Constipation—Metformin—type 2 diabetes mellitus	5.38e-05	0.000267	CcSEcCtD
Tretinoin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000264	CcSEcCtD
Tretinoin—Anorexia—Losartan—type 2 diabetes mellitus	5.32e-05	0.000264	CcSEcCtD
Tretinoin—Vomiting—Glyburide—type 2 diabetes mellitus	5.32e-05	0.000264	CcSEcCtD
Tretinoin—Pruritus—Gliclazide—type 2 diabetes mellitus	5.32e-05	0.000264	CcSEcCtD
Tretinoin—Malaise—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000263	CcSEcCtD
Tretinoin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000262	CcSEcCtD
Tretinoin—Rash—Glyburide—type 2 diabetes mellitus	5.28e-05	0.000262	CcSEcCtD
Tretinoin—Somnolence—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000262	CcSEcCtD
Tretinoin—Dermatitis—Glyburide—type 2 diabetes mellitus	5.27e-05	0.000262	CcSEcCtD
Tretinoin—Syncope—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000261	CcSEcCtD
Tretinoin—Headache—Glyburide—type 2 diabetes mellitus	5.25e-05	0.00026	CcSEcCtD
Tretinoin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000259	CcSEcCtD
Tretinoin—Hypotension—Losartan—type 2 diabetes mellitus	5.22e-05	0.000259	CcSEcCtD
Tretinoin—Palpitations—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000257	CcSEcCtD
Tretinoin—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.18e-05	0.000257	CcSEcCtD
Tretinoin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000256	CcSEcCtD
Tretinoin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000256	CcSEcCtD
Tretinoin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.14e-05	0.000255	CcSEcCtD
Tretinoin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.14e-05	0.000255	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000254	CcSEcCtD
Tretinoin—Cough—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000254	CcSEcCtD
Tretinoin—Fatigue—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000254	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.09e-05	0.000252	CcSEcCtD
Tretinoin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.09e-05	0.000252	CcSEcCtD
Tretinoin—Convulsion—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000252	CcSEcCtD
Tretinoin—Pain—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000252	CcSEcCtD
Tretinoin—Constipation—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000252	CcSEcCtD
Tretinoin—Insomnia—Losartan—type 2 diabetes mellitus	5.05e-05	0.000251	CcSEcCtD
Tretinoin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.03e-05	0.000249	CcSEcCtD
Tretinoin—Paraesthesia—Losartan—type 2 diabetes mellitus	5.02e-05	0.000249	CcSEcCtD
Tretinoin—Urticaria—Metformin—type 2 diabetes mellitus	5e-05	0.000248	CcSEcCtD
Tretinoin—Chest pain—Ramipril—type 2 diabetes mellitus	5e-05	0.000248	CcSEcCtD
Tretinoin—Arthralgia—Ramipril—type 2 diabetes mellitus	5e-05	0.000248	CcSEcCtD
Tretinoin—Myalgia—Ramipril—type 2 diabetes mellitus	5e-05	0.000248	CcSEcCtD
Tretinoin—Dyspnoea—Losartan—type 2 diabetes mellitus	4.98e-05	0.000247	CcSEcCtD
Tretinoin—Anxiety—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000247	CcSEcCtD
Tretinoin—Nausea—Glyburide—type 2 diabetes mellitus	4.97e-05	0.000247	CcSEcCtD
Tretinoin—Abdominal pain—Metformin—type 2 diabetes mellitus	4.97e-05	0.000247	CcSEcCtD
Tretinoin—Dizziness—Gliclazide—type 2 diabetes mellitus	4.97e-05	0.000247	CcSEcCtD
Tretinoin—Somnolence—Losartan—type 2 diabetes mellitus	4.97e-05	0.000246	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000246	CcSEcCtD
Tretinoin—Asthenia—Valsartan—type 2 diabetes mellitus	4.96e-05	0.000246	CcSEcCtD
Tretinoin—Discomfort—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000245	CcSEcCtD
Tretinoin—Dyspepsia—Losartan—type 2 diabetes mellitus	4.92e-05	0.000244	CcSEcCtD
Tretinoin—Asthenia—Orlistat—type 2 diabetes mellitus	4.9e-05	0.000243	CcSEcCtD
Tretinoin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000243	CcSEcCtD
Tretinoin—Pruritus—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000242	CcSEcCtD
Tretinoin—Dry mouth—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000242	CcSEcCtD
Tretinoin—Decreased appetite—Losartan—type 2 diabetes mellitus	4.86e-05	0.000241	CcSEcCtD
Tretinoin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000241	CcSEcCtD
Tretinoin—Confusional state—Ramipril—type 2 diabetes mellitus	4.83e-05	0.00024	CcSEcCtD
Tretinoin—Pruritus—Orlistat—type 2 diabetes mellitus	4.83e-05	0.00024	CcSEcCtD
Tretinoin—Fatigue—Losartan—type 2 diabetes mellitus	4.82e-05	0.000239	CcSEcCtD
Tretinoin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000238	CcSEcCtD
Tretinoin—Oedema—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000238	CcSEcCtD
Tretinoin—Vomiting—Gliclazide—type 2 diabetes mellitus	4.78e-05	0.000237	CcSEcCtD
Tretinoin—Pain—Losartan—type 2 diabetes mellitus	4.78e-05	0.000237	CcSEcCtD
Tretinoin—Constipation—Losartan—type 2 diabetes mellitus	4.78e-05	0.000237	CcSEcCtD
Tretinoin—Rash—Gliclazide—type 2 diabetes mellitus	4.74e-05	0.000235	CcSEcCtD
Tretinoin—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.74e-05	0.000235	CcSEcCtD
Tretinoin—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.73e-05	0.000234	CcSEcCtD
Tretinoin—Urticaria—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000234	CcSEcCtD
Tretinoin—Shock—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000234	CcSEcCtD
Tretinoin—Headache—Gliclazide—type 2 diabetes mellitus	4.71e-05	0.000234	CcSEcCtD
Tretinoin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000233	CcSEcCtD
Tretinoin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000233	CcSEcCtD
Tretinoin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.69e-05	0.000233	CcSEcCtD
Tretinoin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000233	CcSEcCtD
Tretinoin—Tachycardia—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000232	CcSEcCtD
Tretinoin—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000232	CcSEcCtD
Tretinoin—Skin disorder—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000231	CcSEcCtD
Tretinoin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.63e-05	0.00023	CcSEcCtD
Tretinoin—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.6e-05	0.000228	CcSEcCtD
Tretinoin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Tretinoin—Dizziness—Valsartan—type 2 diabetes mellitus	4.57e-05	0.000227	CcSEcCtD
Tretinoin—Anorexia—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000226	CcSEcCtD
Tretinoin—Dizziness—Orlistat—type 2 diabetes mellitus	4.51e-05	0.000224	CcSEcCtD
Tretinoin—Asthenia—Metformin—type 2 diabetes mellitus	4.51e-05	0.000224	CcSEcCtD
Tretinoin—Hypotension—Ramipril—type 2 diabetes mellitus	4.48e-05	0.000222	CcSEcCtD
Tretinoin—Nausea—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000221	CcSEcCtD
Tretinoin—Pruritus—Metformin—type 2 diabetes mellitus	4.45e-05	0.000221	CcSEcCtD
Tretinoin—Urticaria—Losartan—type 2 diabetes mellitus	4.44e-05	0.00022	CcSEcCtD
Tretinoin—Body temperature increased—Losartan—type 2 diabetes mellitus	4.42e-05	0.000219	CcSEcCtD
Tretinoin—Abdominal pain—Losartan—type 2 diabetes mellitus	4.42e-05	0.000219	CcSEcCtD
Tretinoin—Vomiting—Valsartan—type 2 diabetes mellitus	4.39e-05	0.000218	CcSEcCtD
Tretinoin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000217	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000216	CcSEcCtD
Tretinoin—Rash—Valsartan—type 2 diabetes mellitus	4.36e-05	0.000216	CcSEcCtD
Tretinoin—Dermatitis—Valsartan—type 2 diabetes mellitus	4.35e-05	0.000216	CcSEcCtD
Tretinoin—Vomiting—Orlistat—type 2 diabetes mellitus	4.34e-05	0.000215	CcSEcCtD
Tretinoin—Insomnia—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000215	CcSEcCtD
Tretinoin—Headache—Valsartan—type 2 diabetes mellitus	4.33e-05	0.000215	CcSEcCtD
Tretinoin—Diarrhoea—Metformin—type 2 diabetes mellitus	4.3e-05	0.000213	CcSEcCtD
Tretinoin—Rash—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000213	CcSEcCtD
Tretinoin—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000213	CcSEcCtD
Tretinoin—Dermatitis—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000213	CcSEcCtD
Tretinoin—Headache—Orlistat—type 2 diabetes mellitus	4.28e-05	0.000212	CcSEcCtD
Tretinoin—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000212	CcSEcCtD
Tretinoin—Asthenia—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000211	CcSEcCtD
Tretinoin—Somnolence—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000211	CcSEcCtD
Tretinoin—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000209	CcSEcCtD
Tretinoin—Pruritus—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000208	CcSEcCtD
Tretinoin—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000207	CcSEcCtD
Tretinoin—Dizziness—Metformin—type 2 diabetes mellitus	4.16e-05	0.000206	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000205	CcSEcCtD
Tretinoin—Fatigue—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000205	CcSEcCtD
Tretinoin—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.12e-05	0.000204	CcSEcCtD
Tretinoin—Nausea—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000203	CcSEcCtD
Tretinoin—Constipation—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000203	CcSEcCtD
Tretinoin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000201	CcSEcCtD
Tretinoin—Nausea—Orlistat—type 2 diabetes mellitus	4.05e-05	0.000201	CcSEcCtD
Tretinoin—Asthenia—Losartan—type 2 diabetes mellitus	4.01e-05	0.000199	CcSEcCtD
Tretinoin—Vomiting—Metformin—type 2 diabetes mellitus	4e-05	0.000198	CcSEcCtD
Tretinoin—Rash—Metformin—type 2 diabetes mellitus	3.97e-05	0.000197	CcSEcCtD
Tretinoin—Dermatitis—Metformin—type 2 diabetes mellitus	3.96e-05	0.000197	CcSEcCtD
Tretinoin—Pruritus—Losartan—type 2 diabetes mellitus	3.95e-05	0.000196	CcSEcCtD
Tretinoin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000196	CcSEcCtD
Tretinoin—Headache—Metformin—type 2 diabetes mellitus	3.94e-05	0.000195	CcSEcCtD
Tretinoin—Dizziness—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000195	CcSEcCtD
Tretinoin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000194	CcSEcCtD
Tretinoin—Diarrhoea—Losartan—type 2 diabetes mellitus	3.82e-05	0.00019	CcSEcCtD
Tretinoin—Urticaria—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000189	CcSEcCtD
Tretinoin—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000188	CcSEcCtD
Tretinoin—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000188	CcSEcCtD
Tretinoin—Vomiting—Irbesartan—type 2 diabetes mellitus	3.77e-05	0.000187	CcSEcCtD
Tretinoin—Rash—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000186	CcSEcCtD
Tretinoin—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000185	CcSEcCtD
Tretinoin—Nausea—Metformin—type 2 diabetes mellitus	3.74e-05	0.000185	CcSEcCtD
Tretinoin—Headache—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.000184	CcSEcCtD
Tretinoin—Dizziness—Losartan—type 2 diabetes mellitus	3.69e-05	0.000183	CcSEcCtD
Tretinoin—Vomiting—Losartan—type 2 diabetes mellitus	3.55e-05	0.000176	CcSEcCtD
Tretinoin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000175	CcSEcCtD
Tretinoin—Nausea—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000175	CcSEcCtD
Tretinoin—Rash—Losartan—type 2 diabetes mellitus	3.52e-05	0.000175	CcSEcCtD
Tretinoin—Dermatitis—Losartan—type 2 diabetes mellitus	3.52e-05	0.000175	CcSEcCtD
Tretinoin—Headache—Losartan—type 2 diabetes mellitus	3.5e-05	0.000174	CcSEcCtD
Tretinoin—Asthenia—Ramipril—type 2 diabetes mellitus	3.44e-05	0.00017	CcSEcCtD
Tretinoin—Pruritus—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000168	CcSEcCtD
Tretinoin—Nausea—Losartan—type 2 diabetes mellitus	3.32e-05	0.000165	CcSEcCtD
Tretinoin—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000163	CcSEcCtD
Tretinoin—Dizziness—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000157	CcSEcCtD
Tretinoin—Vomiting—Ramipril—type 2 diabetes mellitus	3.05e-05	0.000151	CcSEcCtD
Tretinoin—Rash—Ramipril—type 2 diabetes mellitus	3.02e-05	0.00015	CcSEcCtD
Tretinoin—Dermatitis—Ramipril—type 2 diabetes mellitus	3.02e-05	0.00015	CcSEcCtD
Tretinoin—Headache—Ramipril—type 2 diabetes mellitus	3e-05	0.000149	CcSEcCtD
Tretinoin—Nausea—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000141	CcSEcCtD
Tretinoin—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.89e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	2.88e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.88e-06	1.86e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	2.87e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	2.86e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.86e-06	1.85e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—type 2 diabetes mellitus	2.84e-06	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.83e-06	1.83e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3R1—type 2 diabetes mellitus	2.82e-06	1.82e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NOS3—type 2 diabetes mellitus	2.82e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	2.82e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	2.82e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	2.82e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	2.78e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	2.78e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	2.77e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	2.77e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	2.77e-06	1.79e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	2.76e-06	1.78e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.75e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	2.75e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	2.75e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	2.75e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	2.74e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	2.74e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.73e-06	1.76e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.73e-06	1.76e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	2.73e-06	1.76e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	2.72e-06	1.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.68e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.68e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.68e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.68e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	2.67e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.67e-06	1.73e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	2.67e-06	1.72e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	2.67e-06	1.72e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	2.66e-06	1.72e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.66e-06	1.72e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	2.65e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	2.63e-06	1.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	2.63e-06	1.7e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	2.63e-06	1.7e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	2.61e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.61e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	2.6e-06	1.68e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	2.58e-06	1.67e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—type 2 diabetes mellitus	2.58e-06	1.67e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	2.57e-06	1.66e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	2.55e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	2.54e-06	1.64e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	2.53e-06	1.63e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.52e-06	1.63e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	2.5e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	2.49e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	2.48e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.47e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.47e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	2.47e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	2.47e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	2.47e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	2.47e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.46e-06	1.59e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	2.43e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	2.43e-06	1.57e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	2.42e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	2.42e-06	1.56e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	2.4e-06	1.55e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.4e-06	1.55e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	2.38e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	2.38e-06	1.54e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	2.38e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.37e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.36e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	2.36e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	2.35e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.35e-06	1.51e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	2.33e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	2.32e-06	1.5e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	2.31e-06	1.49e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.29e-06	1.48e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.28e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.28e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.28e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.28e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.28e-06	1.47e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	2.26e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.26e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	2.26e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.25e-06	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	2.25e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	2.25e-06	1.45e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.23e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.23e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.23e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.22e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	2.2e-06	1.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.2e-06	1.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	2.19e-06	1.42e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	2.19e-06	1.41e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.19e-06	1.41e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.17e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.16e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	2.16e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	2.16e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.16e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	2.15e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	2.14e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.14e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.14e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	2.14e-06	1.38e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.11e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	2.1e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.1e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	2.08e-06	1.34e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	2.07e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.07e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.06e-06	1.33e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	2.05e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	2.04e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	2.04e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.03e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.02e-06	1.31e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.02e-06	1.3e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	2.02e-06	1.3e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.01e-06	1.3e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	2e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.99e-06	1.29e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.99e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	1.98e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.97e-06	1.27e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.96e-06	1.26e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.93e-06	1.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.92e-06	1.24e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.9e-06	1.23e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.89e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	1.89e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.89e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	1.89e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.88e-06	1.22e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.86e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.86e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.86e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-06	1.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.84e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.84e-06	1.19e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.83e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.82e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.82e-06	1.18e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.81e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.81e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.81e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.81e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.8e-06	1.16e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	1.78e-06	1.15e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.77e-06	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.76e-06	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.76e-06	1.13e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.75e-06	1.13e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	1.74e-06	1.13e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.74e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.73e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	1.73e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.73e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.71e-06	1.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-06	1.1e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.7e-06	1.1e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.68e-06	1.08e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—type 2 diabetes mellitus	1.67e-06	1.08e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.64e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.64e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.64e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—type 2 diabetes mellitus	1.64e-06	1.06e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.63e-06	1.05e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.63e-06	1.05e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.63e-06	1.05e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	1.04e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.6e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.59e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.58e-06	1.02e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-06	1.02e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.56e-06	1.01e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.55e-06	9.99e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	9.87e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	9.87e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.51e-06	9.75e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.5e-06	9.71e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.49e-06	9.64e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.49e-06	9.64e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.49e-06	9.6e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.48e-06	9.56e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.48e-06	9.53e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	9.53e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.47e-06	9.49e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.47e-06	9.49e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.43e-06	9.26e-06	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-06	9.23e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.41e-06	9.11e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.41e-06	9.11e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.41e-06	9.11e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.41e-06	9.1e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.41e-06	9.1e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.41e-06	9.07e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	9.02e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.39e-06	8.97e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.37e-06	8.82e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.35e-06	8.73e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—type 2 diabetes mellitus	1.3e-06	8.37e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.29e-06	8.35e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.29e-06	8.35e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	8.33e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	7.9e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.22e-06	7.84e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.22e-06	7.84e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.21e-06	7.81e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.2e-06	7.75e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.19e-06	7.7e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.18e-06	7.64e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.16e-06	7.48e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.13e-06	7.27e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.11e-06	7.14e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.1e-06	7.11e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-06	6.99e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.08e-06	6.97e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	6.8e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	6.8e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.05e-06	6.78e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.04e-06	6.7e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	9.96e-07	6.43e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	9.77e-07	6.31e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	9.63e-07	6.22e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	9.5e-07	6.13e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.46e-07	6.11e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.31e-07	6.01e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.27e-07	5.98e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.17e-07	5.92e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	8.71e-07	5.62e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.08e-07	5.21e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.92e-07	5.11e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.26e-07	4.69e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	7.03e-07	4.54e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.95e-07	4.48e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.95e-07	4.48e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	6.87e-07	4.43e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	6.49e-07	4.19e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.35e-07	4.1e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	5.95e-07	3.84e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	4.84e-07	3.13e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.19e-07	2.06e-06	CbGpPWpGaD
